论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Anwaier G, Chen C, Cao Y, Qi R
Received 23 May 2017
Accepted for publication 13 July 2017
Published 19 October 2017 Volume 2017:12 Pages 7681—7693
DOI https://doi.org/10.2147/IJN.S142385
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Thiruganesh Ramasamy
Peer reviewer comments 3
Editor who approved publication: Dr Linlin Sun
Abstract: Despite the fact that technological advancements have been made in
diagnosis and treatment, cardiovascular diseases (CVDs) remain the leading
cause of mortality and morbidity worldwide. Early detection of atherosclerosis
(AS), especially vulnerable plaques, plays a crucial role in the prevention of
acute coronary syndrome (ACS). Targeting the critical cytokines and molecules
that are upregulated during the biological process of AS by in vivo molecular
imaging has been widely used in plaque imaging. With their three-dimensional architecture,
composition, and abundant terminal functional groups, dendrimers provide a
platform for multitargeting and multimodal imaging. Thus, modified dendrimers
with the key molecules upregulated in AS plaques will be an innovative attempt
to achieve targeted imaging of AS plaques specifically and efficiently. This
review was aimed to address some recent works on imaging of AS plaques using
various types of image technology and further discuss the applications of
dendrimers, an innovative yet seldom used method in imaging of AS plaques due
to some limitations and challenges, and we highlight the bright future of the
modified dendrimers in characterizing AS plaques.
Keywords: atherosclerosis
plaques, molecular imaging, dendrimers